 Restaging assessments will be performed at two-month intervals during the receipt of chemotherapy and approximately four to six weeks following the completion of chemoradiation. Treatment response will be assessed by imaging CT scan, biomarker serum CA19-9 and performance status assessment SPPB and CES-D evaluations at the first restaging assessment. 